Using light and sound flicker to help prevent Alzheimer's disease
Gamma Sensory Flicker as an Early Intervention for Alzheimer’s Disease: Mechanisms and Protective Effects
This study is looking at how a special light and sound pattern might help people at risk for Alzheimer's disease by boosting brain health and memory before any serious symptoms show up.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10745092 on NIH RePORTER |
What this research studies
This research investigates the effects of gamma sensory flicker, which involves lights and sounds pulsing at 40Hz, as a potential early intervention for Alzheimer's disease. The team has previously shown that this flicker can reduce harmful amyloid plaques and improve memory in mouse models of Alzheimer's. The current study aims to explore how this flicker stimulation can enhance immune function and neural activity in individuals at risk for Alzheimer's before significant symptoms develop. By utilizing advanced techniques like transcriptomic and proteomic analyses, the researchers will assess the flicker's impact on brain health and memory.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those in the preclinical stages without significant memory deficits.
Not a fit: Patients who are already experiencing advanced Alzheimer's symptoms or significant cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventive strategies for Alzheimer's disease, potentially delaying or preventing the onset of symptoms.
How similar studies have performed: Previous research has shown promising results with similar approaches using sensory stimulation in animal models, indicating potential for success in human applications.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Singer, Annabelle Catherine — Georgia Institute of Technology
- Study coordinator: Singer, Annabelle Catherine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.